Thumbnail for Medication-Related Osteonecrosis of the Jaw (MRONJ) and Osteoporosis7:55
Video

Medication-Related Osteonecrosis of the Jaw (MRONJ) and Osteoporosis

Published:

About

Healthy Bones Australia has released its first Consensus Statement on MRONJ and osteoporosis. This activity provides a quick guide to this new guideline.

This activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours.

Learning Outcomes

  1. Outline the best practice approach to assessing and managing MRONJ risk in osteoporosis care.
  2. Critically reflect on recent interactions with patients requiring dental procedures while receiving ARD therapy.
  3. Apply guideline-aligned strategies to minimise MRONJ risk in patients with osteoporosis.

Provider

The Provider of this activity is Praxhub. Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com.

Provider

Praxhub logo
Praxhub
Health Technology

Host

Arrotex logo
Arrotex
Pharmaceutical

Presenters

Prof Peter Ebeling
Prof Peter Ebeling
Endocrinology

Join the community and start earning CPD hours today.

Free for all healthcare professionals.